- Home
- ALLO vs BAND Comparison
ALLO vs BAND Comparison
Compare ALLO & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | BAND |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 771.9M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALLO | BAND |
|---|---|---|
| Price | $2.07 | $63.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | $8.35 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 9.0M | 1.6M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $204,113,000.00 |
| Revenue This Year | N/A | $15.16 |
| Revenue Next Year | $142,416.42 | $6.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.26 |
| 52 Week Low | $0.99 | $12.50 |
| 52 Week High | $4.46 | $75.98 |
Technical Indicators
Market Signals| Indicator | ALLO | BAND |
|---|---|---|
| Relative Strength Index (RSI) | 49.96 | 59.69 |
| Support Level | $1.85 | $14.27 |
| Resistance Level | $2.36 | $75.98 |
| Average True Range (ATR) | 0.13 | 4.78 |
| MACD | 0.03 | -0.37 |
| Stochastic Oscillator | 60.00 | 78.96 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of its revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.